William O’Neill, MD, and Alejandro Lemor, MD, compare insurance databases to the cVAD registry and discuss factors that characterize high-risk patients requiring MCS.
Prof. Christophe Vandenbriele, MD, urges caution and the need for context when drawing conclusions from retrospective analyses in critically ill patients with cardiogenic shock.
In a third-party analysis conducted by the York Health Economics Consortium, IPD from contemporary studies were evaluated to test the hypothesis that PCI with Impella® support may be associated with a greater extent of revascularization.
Vasileios Panoulas, MD, discusses an individual patient data pooling from the PROTECT II RCT, PROTECT III and RESTORE EF trials released at EuroPCR 2023.
Gregg Stone, MD, FACC, FSCAI interviews Prof. Divaka Perera, professor of cardiology at Kings College in London, UK at the European Society of Cardiology (ESC) Congress 2022 in Barcelona, Spain.